IRIS
ZANGRILLI, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.916
AS - Asia 966
EU - Europa 790
Continente sconosciuto - Info sul continente non disponibili 196
SA - Sud America 139
AF - Africa 14
OC - Oceania 9
Totale 8.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.866
SG - Singapore 396
CN - Cina 225
IT - Italia 158
RU - Federazione Russa 126
BR - Brasile 118
DE - Germania 88
IE - Irlanda 86
HK - Hong Kong 78
VN - Vietnam 75
SE - Svezia 74
FR - Francia 63
GB - Regno Unito 63
UA - Ucraina 53
BD - Bangladesh 52
CA - Canada 34
FI - Finlandia 31
IN - India 30
JP - Giappone 20
KR - Corea 17
UZ - Uzbekistan 15
PL - Polonia 12
MX - Messico 10
AU - Australia 9
KG - Kirghizistan 8
AR - Argentina 7
ES - Italia 7
ID - Indonesia 7
NL - Olanda 7
RO - Romania 7
IQ - Iraq 6
PK - Pakistan 6
TR - Turchia 6
MY - Malesia 5
EC - Ecuador 4
JO - Giordania 4
ZA - Sudafrica 4
AT - Austria 3
BE - Belgio 3
CL - Cile 3
CO - Colombia 3
EG - Egitto 3
MA - Marocco 3
PH - Filippine 3
CH - Svizzera 2
DK - Danimarca 2
IL - Israele 2
KE - Kenya 2
NP - Nepal 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
Totale 7.835
Salva come PNG Salva come JPEG
Città #
Wilmington 1.476
Houston 1.175
Woodbridge 1.101
Singapore 265
Fairfield 222
Ashburn 196
Chandler 196
San Jose 159
Ann Arbor 104
Seattle 89
Cambridge 85
Dublin 81
Beijing 80
Hong Kong 74
Council Bluffs 68
New York 64
Medford 61
Dearborn 45
Jacksonville 45
The Dalles 45
Los Angeles 39
Rome 32
Santa Clara 32
Lawrence 28
Ho Chi Minh City 25
Lauterbourg 23
Tokyo 20
Buffalo 19
Dallas 18
Zhengzhou 18
Helsinki 17
Brooklyn 16
Hanoi 16
Moscow 16
San Diego 16
Milan 14
Montreal 13
Chennai 12
Munich 12
Shanghai 12
Boardman 11
Denver 11
Atlanta 10
São Paulo 10
Warsaw 10
Orem 9
Hefei 8
London 8
Manchester 8
Redondo Beach 8
Seoul 8
Brasília 7
Menlo Park 7
Norwalk 7
Phoenix 7
Redmond 7
Redwood City 7
Stockholm 7
Toronto 7
Bari 6
Chicago 6
Nuremberg 6
Sydney 6
Ankara 5
Belo Horizonte 5
Bologna 5
Detroit 5
Esslingen am Neckar 5
Florence 5
Lappeenranta 5
Mexico City 5
Nanjing 5
Rio de Janeiro 5
San Francisco 5
Amman 4
Boston 4
Charlotte 4
Da Nang 4
Kilburn 4
Palo Alto 4
Poplar 4
Raleigh 4
Sedico 4
Augusta 3
Baghdad 3
Brussels 3
Cagliari 3
City of London 3
Columbus 3
Genazzano 3
Guangzhou 3
Jinan 3
Mülheim 3
Nanchang 3
North Bergen 3
Paris 3
Pasadena 3
Pescara 3
Queens 3
Quảng Ngãi 3
Totale 6.352
Salva come PNG Salva come JPEG
Nome #
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 491
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 483
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 466
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 454
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 426
Erysipeloid cutaneous metastasis from bladder carcinoma 407
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 406
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 401
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. 379
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 360
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab 321
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 279
Paradoxical case effects of psoriasis following adalimumab therapy: A case series 276
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 274
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 245
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 209
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation 205
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 204
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 186
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma 155
Omalizumab and adalimumab: a winning couple 148
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study 146
Ixekizumab: One drug for an enigmatic psoriasis 141
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report 139
Paradoxical psoriasis induced by anti-TNFα treatment: evaluation of disease-specific clinical and genetic markers 133
Clinical severity instruments 129
Risankizumab: How to choose the right dose in clinical practice? 115
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study 112
Long-term efficacy of adalimumab in generalized pustular psoriasis 103
Effectiveness of ixekizumab in elderly patients for the treatment of moderate-to-severe psoriasis: results from a multicenter, retrospective real-life study in the Lazio region 85
Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case–Control 24-Month Longitudinal Study 75
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 74
null 3
Totale 8.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022277 0 0 21 25 10 18 17 12 18 50 19 87
2022/2023439 35 51 23 53 36 95 37 22 45 13 15 14
2023/2024148 14 3 8 5 18 29 12 23 4 9 0 23
2024/2025624 27 119 92 27 6 36 66 28 50 62 69 42
2025/20261.442 126 50 146 145 134 57 227 158 107 137 72 83
2026/2027196 67 76 53 0 0 0 0 0 0 0 0 0
Totale 8.030